Figure 6
Figure 6. Altered PD-L1 and CD40 expression on peritoneal macrophages and splenic DCs from thioglycollate- or LPS-treated Daf−/− mice. (A) FACS analysis of CD40 expression on splenic DCs from LPS-treated WT, Daf−/−, Daf−/−/C3−/− or Daf−/−/C5aR−/− mice. (B) FACS analysis of CD40 and PD-L1 expression on resident peritoneal macrophages from naive WT or Daf−/− mice. (C) FACS analysis of CD40 and PD-L1 expression on thioglycollate-elicited peritoneal macrophages from WT, Daf−/−, Daf−/−/C3−/− or Daf−/−/C5aR−/− mice. All data are representative of 3 independent experiments.

Altered PD-L1 and CD40 expression on peritoneal macrophages and splenic DCs from thioglycollate- or LPS-treated Daf−/− mice. (A) FACS analysis of CD40 expression on splenic DCs from LPS-treated WT, Daf−/−, Daf−/−/C3−/− or Daf−/−/C5aR−/− mice. (B) FACS analysis of CD40 and PD-L1 expression on resident peritoneal macrophages from naive WT or Daf−/− mice. (C) FACS analysis of CD40 and PD-L1 expression on thioglycollate-elicited peritoneal macrophages from WT, Daf−/−, Daf−/−/C3−/− or Daf−/−/C5aR−/− mice. All data are representative of 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal